168
Participants
Start Date
August 26, 2021
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Immunotherapy
All patients must be planned for treatment with any immunotherapy agent after sentinel lymph node biopsy (e.g. pembrolizumab or nivolumab). For patients receiving radiation therapy initiation may be before, during or after radiation.
Quality-of-Life Assessment
Ancillary studies
Radiation Therapy
Undergo nodal radiation therapy
RECRUITING
Baptist - MD Anderson Cancer Center, Jacksonville
RECRUITING
M D Anderson Cancer Center, Houston
RECRUITING
Cooper Hospital UNIV MED CTR., Camden
M.D. Anderson Cancer Center
OTHER